Moderna's Melanoma Vaccine Succeeds in Phase III Trial

A new cancer vaccine using mRNA technology has shown success against melanoma in late-stage trials, opening doors for treatment of lung, bladder, and kidney cancers.

The breakthrough validates a promising approach that primes the immune system to fight cancer cells.